Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
The company was founded by Luther and Charles Perrigo in 1887.
1887: Luther and Charles Perrigo begin packaging generic home remedies and selling them at their own and to other general stores.
In 1887, Luther Perrigo, the owner of a general store and apple-drying business, had the idea to package and distribute patented medicines and household items for country stores.
Luther became president of the firm when it incorporated in 1892.
1921 – Perrigo opens its first plant in Allegan, Michigan.
1921 – Perrigo opens its first plant in Allegan, Michigan. Its second plant opens in 1936.
William L. Tripp, one of Luther Perrigo’s grandchildren, became president in 1967.
When Tripp died in 1969 his son Bill Tripp Jr. took over the presidency.
1980: Perrigo is now the nation's largest private label manufacturer of health and beauty products.
Perrigo acquired Bell Pharmacal Labs of South Carolina in 1984.
1984 – Greenville, South Carolina joined the Perrigo family back in 1984 and is home to a large portion of our vitamin products.
The construction of the graphics department, coupled with other expenses, totals approximately $12.6 million in outlays to the company's printing and graphics department since the Grow purchase in 1986.
A similar acquisition occurred earlier, in January 1992, when Cumberland-Swan, Inc., a Tennessee-based maker of store brand personal care products and vitamins, was bought for $35 million.
An example of this process was Tavist-D, a decongestant and antihistamine that switched from prescription-only to OTC status in 1992.
The investors had purchased company stock through an October 1993 secondary offering, in which mostly shares held by company officials were sold.
The market value of the company in July 1994 based on a closing price of $14 a share was $1 billion, for instance.
While Perrigo management had become accustomed to lawsuits from competitor companies, in July 1994 Perrigo found itself faced with a lawsuit from closer to home.
Perrigo responded in June 1995 with a restructuring involving 180 job cuts, a reduction in distribution centers from seven to four, and a merger of sales and marketing functions across all of the company's product lines.
Two years later, Perrigo reached an agreement with the drug's maker, Sandoz Pharmaceuticals Corp., to begin making a store brand version of Tavist-D in 1995.
With the Grow Group lawsuit still pending, Perrigo received another legal headache in early 1995 when it was the subject of a class-action lawsuit initiated by shareholders.
As reported in the OTC Market Report in 1995, the company is threatened with lawsuits "once or twice a year," but the vast majority of them are settled in a short period of time.
Results for fiscal 1997 were better with both revenues and profits on the upswing.
In June 1998 Perrigo announced that it would sell this unit, which included baby care items, toothpaste, deodorants, and other products, in order to focus on its higher-margin OTC drug and nutritional product lines.
Installation of the system began in September 1998, and it would take 18 months before all of the problems were ironed out.
1998: Perrigo posts a net loss of $51.6 million thanks to a restructuring of its personal care business.
The company did manage to sell its personal care business, offloading it in August 1999 to a Nashville investor group calling itself Cumberland Swan Holdings Inc.
A further cost-cutting move in 1999 involved the elimination of another 130 jobs from the company payroll, a measure aimed at saving as much as $6 million a year.
In May 2000 David T. Gibbons was brought onboard as president and CEO; Jandernoa remained chairman.
Estimates of what this market may be worth vary from $4 billion to $10 billion by the year 2000.
In November 2000, meanwhile, the FDA recommended that phenylpropanolamine (PPA), a key ingredient in many cough and cold remedies, no longer be considered safe because it was believed to cause hemorrhagic stroke.
2001: Perrigo acquires Wrafton Laboratories Ltd., a U.K. maker of store brand pharmaceuticals.
In fiscal 2002 these included store brand equivalents of Excedrin Migraine and Centrum Performance, a multivitamin.
In January 2003 Perrigo's recovery had proceeded to the point where it could count on ongoing cash flow—and could begin paying a dividend for the first time.
Also founded in 2003 was our Perrigo China location, or PCI, where raw material sourcing and quality support is housed.
2004 – Perrigo New Jersey was established in 2004 with the initial goal of developing prescription generic pharmaceuticals.
2005 – Perrigo New York became a part of Perrigo in 2005 and is a state of the art cream and ointment tube plant that produces more than 50 million tubes annually.
Our most diverse and complex operations can be found in Israel, where Perrigo acquired Agis Industries in 2005.
Perrigo's product portfolio expanded in 2005 with the addition of Agis Industries, which added a number of generic prescription pharmaceutical products, primarily focused on difficult to manufacture topical foams, lotions and gels.
2008 – Our consumer healthcare production was enhanced with the addition of Perrigo Michigan-Holland in 2008, through the acquisition of JB Labs, adding contract over the counter and nutritional products to the mix.
2010 – Perrigo’s global expansion continued with the acquisition of Orion Laboratories Pty., Ltd., a leading supplier of over-the-counter store brand pharmaceutical products in Australia and New Zealand.
2011 – In February 2011, Perrigo entered the diabetes care category through an exclusive agreement with AgaMatrix, Inc., to sell and distribute store brand blood glucose monitors and test strips in the United States
2012 – In September 2012, Perrigo announced its intention to enter the animal wellness category by acquiring the assets of Sergeant’s Pet Care Products, Inc., a privately-held manufacturer of over-the-counter companion animal healthcare products.
In 2013, Perrigo acquired Elan Corporation plc, which provided a platform for further global expansion.
In 2015, Perrigo completed the acquisition of Belgium-based Omega Pharma NV, one of the largest OTC self-care companies in Europe.
McManus, Donald C.; Gopnik, Hilary; Salamie, David E. "Perrigo Company ." International Directory of Company Histories. . Retrieved June 21, 2022 from Encyclopedia.com: https://www.encyclopedia.com/books/politics-and-business-magazines/perrigo-company
Perrigo Employees Patent Resources Privacy Notice Cookie Statement Policies and Practices Terms & Conditions US Company Store Contact © 2022 Perrigo Company plc, All Rights Reserved.
Rate Perrigo's efforts to communicate its history to employees.
Do you work at Perrigo?
Is Perrigo's vision a big part of strategic planning?
| Company name | Founded date | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Lannett | 1942 | $340.6M | 1,020 | 13 |
| Evoke Pharma | 2007 | $1.0M | 6 | - |
| Manhattan Drug | 1979 | $43.7M | 100 | - |
| IMAGENETIX | 1996 | $284.9K | 5 | - |
| Qualitest Pharmaceuticals | 1983 | $230.0M | 7,500 | - |
| Par Pharmaceutical Inc | 2003 | $260.0M | 400 | - |
| Sigma-Aldrich | 1951 | $2.8B | 9,600 | - |
| Asahi Kasei America | 1931 | $81.0M | 30,000 | - |
| TISHCON | 1977 | $25.9M | 200 | - |
| Tris Pharma | 2000 | $102.0M | 200 | 8 |
Zippia gives an in-depth look into the details of Perrigo, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Perrigo. The employee data is based on information from people who have self-reported their past or current employments at Perrigo. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Perrigo. The data presented on this page does not represent the view of Perrigo and its employees or that of Zippia.
Perrigo may also be known as or be related to Perrigo, Perrigo Co Of South Carolina, Perrigo Co. Plc, Perrigo Company of South Carolina, Inc., Perrigo Company plc and Perrigo Of Sc Inc.